Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration

International Ophthalmology

Volumn 30, Issue 3, 2010, Pages 267-270

  Ernst, Benjamin J ^a   Barkmeier, Andrew J ^b   Akduman, Levent ^a  

^a Anheuser Busch Eye Institute at St Louis University   (United States)

^b CULLEN EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Optical coherence tomography; Ranibizumab

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; PATIENT SELECTION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77955596756     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-009-9324-9     Document Type: Article

References (7)

1. Rosenfeld PJ, Brown DM, Heier JS et al (2006) MARINA study group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431.
2. Brown DM, Kaiser PK, Michels M et al (2006) ANCHOR study group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444.
3. Chen Y, Wiesmann C, Fuh G et al (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol 293:865-881.
4. Regillo CD, Brown DM, Abraham P et al (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 145:239-248.
5. Fung AE, Lalwani GA, Rosenfeld PJ et al (2007) An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143:566-583.
6. Kaiser PK, Blodi BA, Shapiro H, Acharya NR (2007) MARINA study group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114:1868-1875.
7. Falkenstein IA, Cochran DE, Azen SP et al (2008) Comparison of visual acuity in macular degeneration patients measured with Snellen and early treatment diabetic retinopathy study charts. Ophthalmology 115:319-323.